PharmaEngine, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 154.88 million compared to TWD 177.13 million a year ago. Net income was TWD 87.46 million compared to TWD 73.15 million a year ago. Basic earnings per share from continuing operations was TWD 0.61 compared to TWD 0.51 a year ago. Diluted earnings per share from continuing operations was TWD 0.61 compared to TWD 0.51 a year ago.
For the nine months, sales was TWD 495.91 million compared to TWD 451.03 million a year ago. Net income was TWD 265.17 million compared to TWD 314.5 million a year ago. Basic earnings per share from continuing operations was TWD 1.85 compared to TWD 2.17 a year ago. Diluted earnings per share from continuing operations was TWD 1.85 compared to TWD 2.17 a year ago.